Originally developed for managing type 2 diabetes, this FDA-approved medication is now widely prescribed for weight loss due to its ability to regulate appetite and metabolism
This is legal and there is usually evidence of how the medication can successfully treat the other condition
Within islet cells, GLP-1RAs activate adenylate cyclase to increase the production of intracellular cyclic adenosine monophosphate (cAMP) and to start the subsequent signaling cascade (Figure 1) [28]
Per UHC's official policy, requirements include: BMI of 30+, or BMI of 27+ with a weight-related health condition (high blood pressure, type 2 diabetes, high cholesterol, or sleep apnea), age 12 or older (adolescents need BMI 95th percentile), and evidence of lifestyle changes (diet, exercise, behavioral support)